Rallybio and Johnson & Johnson Join Forces to Combat Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). In a significant move towards advancing healthcare for the most vulnerable, Rallybio Corporation has announced a groundbreaking collaboration with healthcare giant Johnson & Johnson. This partnership is poised to usher in a new era of therapeutic approaches aimed at mitigating the risks associated with feta...
Rallybio股票討論區
In a significant move towards advancing healthcare for the most vulnerable, Rallybio Corporation has announced a groundbreaking collaboration with healthcare giant Johnson & Johnson. This partnership is poised to usher in a new era of therapeutic approaches aimed at mitigating the risks associated with feta...
in
暫無評論